Cargando…

METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and challenging cancers in the world. N6-methyladenosine (m(6)A) modification and long non-coding RNAs (lncRNAs) play critical roles in the progression of HCC. However, there are few reports on genome-wide screening and functional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Runkun, Yin, Guozhi, Tuo, Hang, Guo, Yixian, Zhu, Yifeng, Zhang, Lei, Yang, Wei, Liu, Qingguang, Wang, Yufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472583/ https://www.ncbi.nlm.nih.gov/pubmed/37658413 http://dx.doi.org/10.1186/s13062-023-00409-2

Ejemplares similares

Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA
por: Tuo, Hang, et al.
Publicado: (2023)

LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells
por: Sun, Liankang, et al.
Publicado: (2020)

GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway
por: Chen, Rong, et al.
Publicado: (2023)

Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression
por: Wang, Jun, et al.
Publicado: (2021)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418
por: Wang, Liang, et al.
Publicado: (2019)

lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway
por: Zhao, Qing, et al.
Publicado: (2021)

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction
por: Wang, Liang, et al.
Publicado: (2022)

METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA
por: Meng, Liping, et al.
Publicado: (2022)

METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis
por: Li, Changshu, et al.
Publicado: (2023)

Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma
por: Xia, Xigang, et al.
Publicado: (2021)

The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1
por: Peng, Jiaojiao, et al.
Publicado: (2022)

Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
por: Wang, Liang, et al.
Publicado: (2021)

MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma
por: Tuo, Hang, et al.
Publicado: (2017)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway
por: Yang, Nan, et al.
Publicado: (2020)

LncRNA-Smad7 mediates cross-talk between Nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells
por: Kong, Xiaohui, et al.
Publicado: (2022)

LncRNA EPR-induced METTL7A1 modulates target gene translation
por: Briata, Paola, et al.
Publicado: (2022)

LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling
por: Zhang, Yiming, et al.
Publicado: (2023)

LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis
por: Liu, Yang, et al.
Publicado: (2021)

A Non-Invasive Nomogram for Preoperative Prediction of Microvascular Invasion Risk in Hepatocellular Carcinoma
por: Wang, Huanhuan, et al.
Publicado: (2021)

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2018)

HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
por: Chen, Tianxiang, et al.
Publicado: (2021)

The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p
por: Straniero, Letizia, et al.
Publicado: (2017)

Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis
por: Liu, Yang, et al.
Publicado: (2022)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin
por: Chen, Yiran, et al.
Publicado: (2023)

Correction to ‘LncRNA-Smad7 mediates cross-talk between nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells’
Publicado: (2023)

BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells
por: Zhong, Jiamin, et al.
Publicado: (2023)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14
por: Li, Jiajia, et al.
Publicado: (2022)

lncRNA PDCD4-AS1 Promotes the Progression of Glioma by Regulating miR-30b-3p/METTL7B Signaling
por: Li, Zuowei, et al.
Publicado: (2023)

The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis
por: Xu, Jin, et al.
Publicado: (2017)

TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling
por: Iyengar, Prasanna Vasudevan, et al.
Publicado: (2022)

A novel nomogram predicting the early recurrence of hepatocellular carcinoma patients after R0 resection
por: Wang, Huanhuan, et al.
Publicado: (2023)

Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression
por: Ma, Danhui, et al.
Publicado: (2021)

BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
por: Yin, Guozhi, et al.
Publicado: (2016)

Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2019)

A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression
por: Xu, Kequan, et al.
Publicado: (2022)

MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fsbrpgp2d9iv9s9atkbai588h1